openPR Logo
Press release

Stargardt Disease Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Alkeus, Astellas, Belite Bio, IVERIC, Kubota Vision, Nanoscope Therapeutics, ProQR Therapeutics, ReVision Therapeutics, Stargazer

08-11-2023 06:03 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Stargardt Disease Pipeline Assessment (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 18+ key pharma and biotech companies are working on 20+ pipeline drugs in the Stargardt Disease therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Stargardt Disease Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Stargardt Disease Therapeutics Market.

The report provides a detailed description of the Stargardt Disease drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Stargardt Disease Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Stargardt Disease Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Stargardt Disease therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Stargardt Disease treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Stargardt Disease drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Stargardt Disease treatment market.

Learn More about the Clinical and Commercial Development Activities in the Stargardt Disease Therapeutics Domain:
https://www.delveinsight.com/report-store/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Stargardt Disease Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Route of Administration
Stargardt disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Stargardt Disease Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Stargardt Disease Therapeutics Analysis
Several major pharma and biotech companies are developing therapies for Stargardt disease. Currently, Belite Bio is leading the therapeutics market with its Stargardt disease drug candidates in the most advanced stage of clinical development.

Stargardt Disease Companies in the Therapeutics Market Include:
• Alkeus Pharmaceuticals
• Astellas Pharma
• Belite Bio
• IVERIC bio
• Kubota Vision
• Nanoscope Therapeutics
• ProQR Therapeutics
• ReVision Therapeutics
• Stargazer Pharmaceuticals, Inc.
And many others

Stargardt Disease Therapies covered in the report include:
• Tinlarebant: Belite Bio
• ASP7317: Astellas Pharma
• QR-1011: ProQR
And many more

Get an in-depth Assessment of the Emerging Therapies and Stargardt Disease Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Stargardt Disease Current Treatment Patterns
4. Stargardt Disease - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Stargardt Disease Late-Stage Products (Phase-III)
7. Stargardt Disease Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Stargardt Disease Discontinued Products
13. Stargardt Disease Product Profiles
14. Stargardt Disease Companies
15. Stargardt Disease Drugs
16. Dormant and Discontinued Products
17. Stargardt Disease Unmet Needs
18. Stargardt Disease Future Perspectives
19. Stargardt Disease Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Schizophrenia Market
https://www.delveinsight.com/report-store/schizophrenia-market

Human Immunodeficiency Virus Type-1 (HIV-1) Market
https://www.delveinsight.com/report-store/human-immunodeficiency-virus-type-1-hiv-1-market

US Healthcare Outlook Bulimia Nervosa Market
https://www.delveinsight.com/report-store/bulimia-nervosa-market

Hepatitis B Virus (HBV) Infection Market
https://www.delveinsight.com/report-store/hepatitis-b-virus-hbv-infection-market

Pancreatic Cancer Market
https://www.delveinsight.com/report-store/pancreatic-cancer-market

Hepatitis C Market
https://www.delveinsight.com/report-store/hepatitis-c-market

Obsessive-Compulsive Disorder Market
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market

Cytomegalovirus (CMV) Infections Market
https://www.delveinsight.com/report-store/cytomegalovirus-cmv-infection-market-insight-epidemiology-and-market-forecast

Spinal Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-fusion-devices-market

Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market

Giant-Cell Arteritis Market
https://www.delveinsight.com/report-store/giant-cell-arteritis-market

Traveler's Diarrhea Market
https://www.delveinsight.com/report-store/travelers-diarrhea-market

Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market

Patent Foramen Ovale (PFO) Closure Devices Market
https://www.delveinsight.com/report-store/patent-foramen-ovale-closure-devices-market

Invasive Pneumococcal Disease Market
https://www.delveinsight.com/report-store/invasive-pneumococcal-disease-market

Echocardiography Devices Market
https://www.delveinsight.com/report-store/echocardiography-devices-market

Primary Immune Deficiency (PID) Market
https://www.delveinsight.com/report-store/primary-immune-deficiency-pid-market

Narcolepsy Market
https://www.delveinsight.com/report-store/narcolepsy-market

Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market

Postoperative Nausea and Vomiting (PONV) Market
https://www.delveinsight.com/report-store/postoperative-nausea-and-vomiting-ponv-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market

Hemodynamic Monitoring Systems Market
https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market

Peripheral Neuritis Market
https://www.delveinsight.com/report-store/peripheral-neuritis-market

Food Allergy Market
https://www.delveinsight.com/report-store/food-allergy-market-insights

Embolotherapy Market
https://www.delveinsight.com/report-store/embolotherapy-market

Psychosis Market
https://www.delveinsight.com/report-store/psychosis-market

Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market

Asthma Market
https://www.delveinsight.com/report-store/asthma-market

Spinal Non-Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-non-fusion-devices-market

Corneal Dystrophy Market
https://www.delveinsight.com/report-store/corneal-dystrophy-market

Myasthenia Gravis Market
https://www.delveinsight.com/report-store/myasthenia-gravis-market

Substance use disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market

Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market

Injectable Drug Delivery Devices Market
https://www.delveinsight.com/report-store/injectable-drug-delivery-devices-market

Atherectomy Devices Market
https://www.delveinsight.com/report-store/atherectomy-devices-market

Chemotherapy Induced Nausea and Vomiting Market
https://www.delveinsight.com/report-store/chemotherapy-induced-nausea-and-vomiting-market

Structural Heart Devices Market
https://www.delveinsight.com/report-store/structural-heart-devices-market-market

Diabetic Eye Disease Market
https://www.delveinsight.com/report-store/diabetic-eye-disease-market

Tissue Heart Valves Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market

Cardiovascular Prosthetic Devices Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market

Diabetic Macular Edema (DME) Market
https://www.delveinsight.com/report-store/diabetic-macular-edema-dme-market

End-Stage Renal Disease (ESRD) Market
https://www.delveinsight.com/report-store/end-stage-renal-disease-esrd-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Renal Insufficiency Market
https://www.delveinsight.com/report-store/renal-insufficiency-market

Diabetic Retinopathy Market
https://www.delveinsight.com/report-store/diabetic-retinopathy-market

Artificial Cornea and Corneal Implant Market
https://www.delveinsight.com/report-store/artificial-cornea-and-corneal-implant-market

Herpes Simplex Market
https://www.delveinsight.com/report-store/herpes-simplex-market

Cardiac Monitoring System Market
https://www.delveinsight.com/report-store/cardiac-monitoring-system-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stargardt Disease Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Alkeus, Astellas, Belite Bio, IVERIC, Kubota Vision, Nanoscope Therapeutics, ProQR Therapeutics, ReVision Therapeutics, Stargazer here

News-ID: 3163299 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and